We also found that SOX2 overexpression elevated SKP2 (S-phase kinase-associated protein 2) expression, which accelerated Sp1 protein degradation, thereby reducing Sp1-regulated FOXO1 expression and ultimately promoting BC invasion. Here, SKP2 is linked to breast cancer.